Evaluation of brain natriuretic peptide (BNP) as a marker of cirrhotic cardiomyopathy in hepatocellular carcinoma patients before and after Radiofrequency ablation
Mohammad Saeed Ibraheem Toaima;
Abstract
Summary and conclusion
Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation and electrophysiological abnor
Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation and electrophysiological abnor
Other data
| Title | Evaluation of brain natriuretic peptide (BNP) as a marker of cirrhotic cardiomyopathy in hepatocellular carcinoma patients before and after Radiofrequency ablation | Other Titles | تقييم الهرمون الدماغي المدر للصوديوم كدليل لضعف عضلة القلب نتيجة لتليف الكبد في مرضى سرطان الكبد قبل وبعد العلاج بالتردد الحراري. | Authors | Mohammad Saeed Ibraheem Toaima | Keywords | Evaluation of brain natriuretic peptide (BNP) as a marker of cirrhotic cardiomyopathy in hepatocellular carcinoma patients before and after Radiofrequency ablation | Issue Date | 2013 | Description | Summary and conclusion Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation and electrophysiological abnor |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 117024g235.pdf | 594.48 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.